Sorrento Therapeutics Stock Price - SRNE

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
After Hours
Last Trade
Last $ 1.58 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Sorrento Therapeutics Inc SRNE NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.01 0.64% 1.58 1.63 1.50 1.57 1.57 17:59:42
Bid Price Ask Price Spread Spread % News
1.55 1.63 0.08 4.91% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
3,674 1,292,147 $ 1.57 $ 2,026,781 1,891,463 1.39 - 6.50
Last Trade Time Type Quantity Stock Price Currency
17:56:14 formt 492 $ 1.58 USD

Sorrento Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 224.16M 141.87M $ -203.54M -1.91 - 37.42M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Sorrento Therapeutics News

Loading Messages....

Latest SRNE Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SRNE Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.661.711.501.641,201,378-0.08-4.82%
1 Month1.711.731.491.591,001,175-0.13-7.6%
3 Months2.322.911.391.831,405,209-0.74-31.9%
6 Months3.634.171.392.311,155,640-2.05-56.47%
1 Year3.556.501.393.131,625,706-1.97-55.49%
3 Years6.2510.651.394.461,532,797-4.67-74.72%
5 Years4.27226.801.395.411,076,585-2.69-63.01%

Sorrento Therapeutics Description

Sorrento Therapeutics Inc is a biotechnology company focused on the development of novel immunotherapies for oncology and autoimmune/inflammation diseases. The antibody technologies target various locations: extracellular, intracellular, and membrane-bound antigens. The product portfolio consists of BioSimilar/BioBetter antibodies, CAR-T programs for treatment of solid tumors, adoptive cellular therapies, immuno-oncology mAbs, and antibody drug conjugates.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.